Grafa News and Videos — Page 8

Milestone Pharmaceuticals (NASDAQ:MIST) received regulatory approval from China's National Medical Products Administration for its etripamil nasal spray, triggering a $2 million milestone payment.

Pharvaris (NASDAQ:PHVS) presented translational, nonclinical, and clinical data on its oral bradykinin B2 receptor antagonist deucrictibant at the Bradykinin Symposium 2026 in Berlin.

The Buckle (NYSE:BKE) reported August 2026 sales results, with net sales increasing 3.6% year over year to $123.5 million for the four-week fiscal month ended August 29, 2026.

ScottsMiracle-Gro (NYSE:SMG) plans to acquire the Black Kow brand after exercising its purchase option with Organics Management, with the transaction expected to close in October 2026.

BitFuFu (NASDAQ:FUFU) reported unaudited August 2026 operational results, with Bitcoin production increasing to 174 BTC, up 55.4% from July 2026.

Aptevo Therapeutics (NASDAQ:APVO) reported clinical results showing that 13 of 14 evaluable frontline TP53-mutated acute myeloid leukemia (AML) patients treated with its mipletamig triplet regimen achieved clinical benefit.

CollPlant Biotechnologies (NASDAQ:CLGN) completed its acquisition of Israeli deep-tech company LightSolver, expanding into high-performance computing and photonics while continuing its existing regenerative medicine operations.

Innovative Eyewear (NASDAQ:LUCY) reported quarterly revenue exceeding $1 million for the first time in the third quarter of 2026, while expanding retail distribution and developing new smart eyewear products.

AbbVie (NYSE:ABBV) completed its acquisition of Apogee Therapeutics (NASDAQ:APGE), paying $135.11 per share in cash for an equity value of approximately $10.9 billion as of September 3, 2026.

Amber International Holding (NASDAQ:AMBR) reported unaudited second quarter 2026 revenue of US$13.9 million, up 38.8% from the previous quarter, as the company returned to positive operating income and net profit.